drugset / Trial / NCT07135453

Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines

NCT07135453

RandomizedParallel-groupOpen-labelBasic science

Summary

The goal of this study is to learn whether different types of vaccines to prevent bacterial infections are able to effectively create antibodies that defend against certain types of bacteria. We will give two different types of vaccine and evaluate the effectiveness of antibodies produced by each vaccine in killing bacteria.

Timeline

Start
2026-07
Primary completion
2027-03
Completion
2027-08

Drugs

EvaluationDrugModalityDoseRoute
Subject PCV20 Vaccine
Subject PCV21 Vaccine